Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Grazia, Pionelli"'
Autor:
Maria Grazia Pionelli, Federica Mazio, Maria Elena Errico, Carmela Russo, Adriana Cristofano, Eugenio Maria Covelli, Vittoria Donofrio, Maria Capasso, Michele Antonio Capozza, Fabiola De Gregorio, Serena Ruotolo, Massimo Eraldo Abate, Giuseppe Cinalli
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The development of cerebral cavernous malformations (CCMs) is a well-recognized sequela of irradiation to the brain in pediatric tumors, particularly in medulloblastoma, glioma, and acute lymphoblastic leukaemia. So far, only one case of cerebral cav
Externí odkaz:
https://doaj.org/article/1ce557d22502431a8cc48c0e438fac2a
Autor:
Maria Grazia, Pionelli, Sebastian D, Asaftei, Elisa, Tirtei, Anna, Campello, Gianpaolo, Di Rosa, Franca, Fagioli
Publikováno v:
Journal of Pediatric Hematology/Oncology. 44:201-209
Giant cell tumors (GCTs) of the skull base are rare entities. Although considered histologically benign, GCTs are locally aggressive with a high rate of local recurrence. The present case describes a 14-year-old girl with a clival GCT who underwent l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80504cd7768235c001cc1174af6f46db
https://doi.org/10.1097/mph.0000000000002477
https://doi.org/10.1097/mph.0000000000002477
Publikováno v:
Medico e Bambino pagine elettroniche. 25:35-38
The paper describes the case report of a sepsis due to Yersinia enterocolitica in an ex preterm infant of 32 weeks’ gestational age with birth weight of 1,220 g. The infant was admitted at 39 weeks postconceptual age to the emergency room for fever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5342692d8b761fdf6b0696db23406d52
https://doi.org/10.53126/mebxxv035
https://doi.org/10.53126/mebxxv035
Autor:
Maria Grazia Pionelli, Sebastian Dorin Asaftei, Cristina Meazza, Alessandra Longhi, Angela Tamburini, Luca Coccoli, Alessandra Merlini, Celeste Cagnazzo, Tirtei Tirtei, Franca Fagioli
Publikováno v:
Journal of Clinical Oncology. 40:11520-11520
11520 Background: Currently, there is no accepted standard chemotherapy regimen for recurrent osteosarcoma. We performed a retrospective study to evaluate the effectiveness, toxicity and clinical benefit of second line therapy with Gemcitabine (G) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b015ae661814c1c17902e1f3ac0ecab
https://doi.org/10.1200/jco.2022.40.16_suppl.11520
https://doi.org/10.1200/jco.2022.40.16_suppl.11520